Research

NAMs, Safety, Bioethics, Predictivity

Interests

I sponsor the group at AstraZeneca that is responsible for accelerating the integration of all NAMs across preclinical pipelines. I also lead in vivo capabilities in the U.K., delivering across all AstraZeneca’s pipelines.